In efforts made by the US to stop the spread of the coronavirus, a new test kit has been developed and would be made available to people to enable them collect their own samples using the device which is known as Pixel by LabCorp COVID-19 Test home collection kits.
“Throughout this pandemic we have been facilitating test development to ensure patients access to accurate diagnostics, which includes supporting the development of reliable and accurate at-home sample collection options,” FDA Commissioner Dr. Stephen Hahn said in the agency’s announcement.
More than 788,900 cases of coronavirus have been reported with at least 42,450 deaths, according to Johns Hopkins University on Tuesday.
“The FDA’s around-the-clock work since this outbreak began has resulted in the authorization of more than 50 diagnostic tests and engagement with over 350 test developers,” Hahn said. “Specifically, for tests that include home sample collection, we worked with LabCorp to ensure the data demonstrated from at-home patient sample collection is as safe and accurate as sample collection at a doctor’s office, hospital or other testing site. With this action, there is now a convenient and reliable option for patient sample collection from the comfort and safety of their home.”
The LabCorp kit includes a specific Q-tip-style cotton nasal swab for patients to use to collect their sample. The upfront pricing of the test is $119, according to the company’s website.
“Our at-home collection kits are designed to make it easier and safer to test healthcare workers and first responders during this important time,” Adam Schechter, president and CEO of LabCorp, said in a company release.
The FDA said in its announcement that, “It is important to note that this is not a general authorization for at-home collection of patient samples using other collection swabs, media, or tests, or for tests fully conducted at home.”
by Mawusi Tawiah
